|
|
Elly Stolk, Ph.D. I am assistant professor in economic evaluation and the distribution of health care at Erasmus Medical Center in Rotterdam. I have had an appointment at the institute for Medical Technology Assessment (iMTA) of Erasmus MC since 1997. My main interests are in the measurement of individual and social preferences for informing health care decision-making. This includes both preferences for the quality of life in different health states and preferences regarding equity in the distribution of health. In 2005 I have finished my dissertation on the subject of the integration of equity concerns into the framework of economic evaluations: ‘Equity and efficiency in health care priority setting. How to get the balance right?’ I teach in the areas of economic evaluation, quality of life research, and reimbursement policies. Date of birth: 10-01-1975 Academic background Current
position -
At this moment I work fulltime as assistant professor
at the iMTA, of the Erasmus MC in Past experience -
2005 - present: Senior researcher at the iMTA, Erasmus MC -
2005: Ph.D. graduation on the topic: Equity and
Efficiency in Health Care Priority Setting: how to Get the Balance Right? -
1998: M.Sc. graduation in Health Sciences, -
1997-1998: Student assistant (research), institute for
Medical Technology Assessment, -
1993: Graduation Christelijk
Gymnasium Research Grants I have
received financial support from the Netherlands Organisation
for Health Research and Development (ZONMW) and the Netherlands Organisation
for Scientific Research (NWO) for the following research projects: -
2007: Project 80-007022-98-07417
“Cost-effectiveness of the Demands and Capacities Model based treatment
compared to the Lidcombe programme
of early stuttering intervention: Randomised
trial” -
2004: 253-20-022 “The Third Man: The Role of
Budget Impact with respect to Dutch Drug Reimbursement Policy” -
2002: ZONMW
Verdelingsvraagstukken 1490.0006 “Integratie van
rechtvaardigheidsoverwegingen in doelmatigheidsonderzoek: een toepassing” -
2001: project 945-10-034 "Integrating normative
considerations into HTA research" Teaching International
lectures: -
University Pompeu Fabra, -
International Society for Pharmacoeconomics
and Outcomes Research, Short course presenter on Utility Measurement, 2004
– today -
-
International Society for Pharmacoeconomics
and Outcomes Research, Balancing economic and equity concerns in health care
resource allocation, 2001 -
Erasmus CMDz, Graduate
courses -
2003-2005, Erasmus University Rotterdam, Medical
Technology Assessment & Health care resource allocation Undergraduate
Courses -
2000-2002, -
1998-2000, -
1995-1997, Ph.D. Supervision -
Caroline Koedoot (started
June 2007) -
Maartje Niezen (started September 2005) Professional
activities Referee for: -
Pharmacoeconomics, Social
Science and Medicine, Health Policy, Medical Decision Making, Quality of Life
Research, Value in Health Memberships of professional
committees -
1999 – present: Member of the Dutch Medical
Technology Assessment Association -
2000 – present: International Society for Pharmacoeconomics and Outcomes Research -
2001 – present: Member of the International
Health Economics Association Publications International
publications in peer reviewed journals -
Stolk EA, de Bont A,
van Halteren AR, Bijlmer RJ, Poley
MJ. Role
of health technology assessment in shaping the benefits package in The
Netherlands. Expert Rev Pharmacoecon Outcomes Res.
2009 Feb;9(1):85-94. -
Ringburg AN, Buljac M, Stolk EA,
van Lieshout EM, van Beeck
EF, Patka P, Schipper IB. Willingness
to pay for lives saved by Helicopter Emergency Medical Services. Prehosp Emerg Care. 2009
Jan-Mar;13(1):37-43 -
Niezen MG, de Bont A, Busschbach JJ, Cohen JP, Stolk EA. Finding
legitimacy for the role of budget impact in drug reimbursement decisions. Int J Technol Assess Health Care.
2009 Jan;25(1):49-55. -
Cohen JP, Stolk
EA, Niezen M. Role of budget impact in drug
reimbursement decisions. J Health Polit Policy Law. 2008 Apr;33(2):225-47. -
Cohen JP, Stolk
EA, The increasingly complex fourth hurdle for pharmaceuticals. Pharmacoeconomics. 2007;25(9):727-34. -
Niezen M, de Bont A, Stolk E, Eyck A, Niessen
L, Stoevelaar H. Conditional reimbursement within the
Dutch drug policy. Health Policy. 2007 Nov;84(1):39-50.
-
Niezen MG, Stolk EA, Steenhoek A, Uyl-De Groot CA. Inequalities in oncology care:
Economic consequences of high cost drugs. Eur J Cancer. 2006 Nov;42(17):2887-92. -
Boot HJ, De
Melker HE, Stolk EA, De Wit GA,
Kimman TG. Assessing the introduction of universal varicella
vaccination in the Netherlands. Vaccine 2006; 24:6288-99 -
De Bont A, Zandwijken G, Stolk E, Niessen L.
Prioritisation by physicians in the Netherlands-The
growth hormone example in drug reimbursement decisions. Health Policy, 2006 (forthcoming) -
Baltussen R, Stolk
E, Chisholm D, Aikins M. Towards a multi-criteria
approach for priority setting: an application to Ghana. Health Econ. 2006 Jul; 15(7):689-96 -
Stolk EA, Rutten FF. The "health benefit basket" in the
Netherlands. Eur J Health Econ. 2005 Dec; Suppl:53-7 -
Stolk EA, Poleij MJ. Criteria for determining a basic health services
package: recent developments in The Netherlands. European Journal Health Economics 2005;6(1):2-7 -
Bleichrodt H, Doctor
J, Stolk E. A nonparametric elicitation of the equity-efficiency trade-off in
cost-utility analysis. J Health Econ. 2005 Jul;24(4):655-78.
-
Stolk EA, Pickee SJ, Ament AH, Busschbach JJV. Equity in health care prioritisation:
an empirical inquiry into social value, Health Policy 2005;74(3):343-55 -
Bleichrodt H, Doctor
J, Stolk EA. A nonparametric
elicitation of the equity-efficiency tradeoff in cost-utility analysis. J Health Econ 2004; 24:655-78 -
Brouwer WBF,
Van Exel JA, Stolk
EA. Acceptability of less than perfect health states. Soc. Sci. Med. 2005; 60: 237-46 -
Stolk EA, Van Donselaar G, Brouwer WBF, Busschbach
JJV. Reconciliation of economic concerns and health policy: illustrattion of an equity adjustment procedure using
proportional shortfall. Pharmacoeconomics 2004; 17: 1097-1107 -
Redekop WK, Stolk EA, Kok E, et al. Diabetic
foot ulcers and amputations: estimates of health utility for us ein cost-effectiveness analyses of new treatments. Diab Metab 2004; 30(6): 549-556 -
Poley MJ, Stolk EA, Rutten
FFH, Molenaar JC, Busschbach
JJV. Short term and long term quality of life after congenital anorectal malformation and congenital diaphragmatic hernia.
Archives of disease in childhood 2004, 89 (9): 836-41 -
Stolk EA, Busschbach JJV. Validity and feasibility of the use of
condition-specific outcome measures in economic evaluation. Qual Life Res 2003; 12(4): 363-371 -
Stolk EA, Busschbach JJV. Are patients and the general public
like-minded about the effect of erectile dysfunction on quality of life? Urology 2003; 61(4):810-815 -
Kok ET, McDonnel J, Stolk EA,
Stoevelaar H, Busschbach
JJV on behalf of the Triumph Research Group. The valuation of the International
Prostate Symptom Score (IPSS) for use in economic evaluations. European urology 2002 Nov; 42:491-7 -
Poley MJ, Stolk EA, Tibboel
D, Molenaar JC, Busschbach
JJ. The cost-effectiveness of treatment for congenital diaphragmatic hernia. J Pediatr Surg 2002 Sep;37(9):1245-52 -
Stolk EA, Brouwer WBF, Busschbach JJV.
Rationalising rationing: economic and other considerations in the debate about
funding of Viagra, Health Policy 2002;59:1:53-63 -
Poley MJ, Stolk EA, Langemeijer
RATM, Molenaar JC, Busschbach
JJV. The cost-effectiveness of neonatal surgery and subsequent treatment for
congenital anorectal malformations, Journal of Pediatric Surgery 2001, Vol. 36
(10): 1471-8 -
Stolk EA, JJV Busschbach JJV. A comparison of the EuroQol
and the Health Utilities Index in patients treated for congenital anomalies. HEPAC European Journal of Health Economics 2001;2:54-60 -
McDonnell J, Busschbach JJ, Kok E, Exel Jv,
Stolk E, Koopmanschap M, Rutten
FFH. Lower urinary tract symptoms suggestive of benign prostatic obstruction -
Triumph: health-economical analysis. European Urology 2001;39:Suppl 3:37-41 -
Stolk EA, Busschbach JJV, Caffa M, Meuleman EJH, Rutten FFH. Cost
utility analysis of sildenafil compared with papaverine-phentolamine injections. British Medical Journal 2000;320:1165-68 -
Stolk EA, Busschbach JJV, Vogels T.
Performance of the EuroQol in children with
imperforate anus. Quality of Life Research 2000;9:29-38 -
Stolk EA, Post HA, Rutten FFH, Molenaar
JC, Busschbach JJV. Cost-effectiveness of
neonatal surgery: a review. Journal of Pediatric Surgery 2000;35:588-92 Reports -
Stolk EA, De Bont A, Poley MJ, Jerak S, Stroet M, Rutten FFH. International
comparison of systems to determine entitlements to medical specialist care:
performance and organizational issues. Institute for medical Technology Assessment/instituut Beleid en Management Gezondheidszorg, report 08.104, Rotterdam, Nederland, 2008 -
Stolk E, Rutten FFH. The
health basket in the Netherlands. A contribution to Work Package II of the EU
funded research project “HealthBASKET”:
Description of benefits, entitlements, actors and decision making processes in
the Dutch health care sector. Institute for medical Technology
Assessment/instituut Beleid en Management
Gezondheidszorg, report 05.75, Rotterdam, Nederland, 2005 Publications in Dutch -
Van Nooten, Stolk E.A., Steenhoek A. De definitie van specialistische geneesmiddelen. Institute for
medical Technology Assessment/instituut Beleid en Management Gezondheidszorg,
report 06.81, Rotterdam, Nederland, 2006 -
Nieboer, Stolk, Koolman Toekomstvisie langdurige zorg en ondersteuning
vanuit burgerperspectief. Institute for medical Technology
Assessment/instituut Beleid en Management
Gezondheidszorg, report 06.79, Rotterdam, Nederland, 2006 -
Brouwer WBF,
Van Exel JA, Stolk
EA. Wat heet gezond? De aanvaardbaarheid van ongezondheid op latere
leeftijd. Tijd van leven, tijd van zorgen. A. Wagemakers,
J. Ubachs-Moust and L. Christ.
Utrecht, Expertisecentrum Leeftijd, 2005 -
Van der Zwet M, Stolk E, Eyck A et al. Evaluatie
van Bijlage 2 als beleidsinstrument. Instituut voor Beleid en Management
Gezondheidszorg, Rotterdam, 2004 -
De Bont A, De
Vos D, Stolk EA, Niessen
L, Stoevelaar H. Evaluatie landelijke beoordeling en
registratie groeihormoon, IBMG, 2004 -
Poley MJ, Stolk EA, Brouwer WBF, et al (2002) Ziektelast als uitwerking van
het criterium 'noodzakelijkheid' bij het maken van keuzen in de zorg. Ned Tijdschr Geneesk
146(48): 2312-2315 -
Poley MJ, Stolk EA, Brouwer WBF, Busschbach JJV.
Ziektelast als criterium. Overheid wil geneesmiddelenpakket
beperken. Medisch Contact 2002; 57(46): 1697-1700. -
Stolk EA, M.J. Poley, W.B.F. Brouwer, J.J. van Busschbach,
Proeftoetsing van het iMTA-model. Identificatie van aandoeningen
met minimale ziektelast en proeftoetsing van de voor ziektelast gecorrigeerde
doelmatigheidstoets, In: W.G.M. Toenders, Vervolgonderzoek breedte
geneesmiddelenpakket, Amstelveen,
College voor Zorgverzekeringen, 2002, bijlage 2. -
Stolk EA, Goes ES, Kok
ET, Busschbach JJV. Uitwerking criteria
noodzakelijkheid, eigen rekening en verantwoording en lifestyle. In: Breedte
Geneesmiddelenpakket. Publicatienummer 01/05, 27 april 2001,
College voor Zorgverzekeringen, Amstelveen -
Stolk EA, Brouwer WBF, Busschbach JJV. Vergoeding Viagra stuit op waarden en normen.
Medisch Contact 2000;55:626-29 Book
chapters -
Stolk, E.
and J. Busschbach (2002). Economics and ethics in
health care. Where can they meet? Between technology and humanity. The impact
of technology on health care ethics. C. Gastmans.
Leuven, Leuven University press: Chapter 3, p. 49-66 -
Stolk EA, Koolman X, Busschbach JJV. Kosteneffectiviteit: een hulpmiddel bij het
maken van keuzes in de zorg? In: Wagemakers A, Wijk Pvd, Francissen P. Wanneer
is het leven te kostbaar. Leeftijd en kosteneffectiviteit in de
gezondheidszorg. Pagina 41-50. Landelijk Bureau Leeftijdsdiscriminatie,
Utrecht, Uitgeverij Boom, Amsterdam ISBN: 90 5352 666 8, 2000. -
Stolk EA, Busschbach JJV. Keuzes in de zorg: de rol van leeftijd,
normen en waarden naast economische overwegingen. In: Wagemakers
A, Wijk Pvd, Francissen P.
Wanneer is het leven te kostbaar. Leeftijd en kosteneffectiviteit in de
gezondheidszorg. Pagina 51-8.
Landelijk Bureau Leeftijdsdiscriminatie, Utrecht, Uitgeverij Boom, Amsterdam
ISBN: 90 5352 666 8, 2000. Other publications -
Stolk EA.
Equity and Efficiency in Health Care Priority Setting: how to Get
the Balance Right? Doctoral thesis, Erasmus University Rotterdam, 2005. PHD
thesis -
Stolk E, van Nooten F. Values for resource allocation
should expose the adaptation process, not the outcome. Virtual -
Stolk E, Busschbach J. Cost effectiveness of sildenafil
calls for political discussion. BMJ.
2000 Aug 19-26;321(7259):510 . -
Stolk EA, Busschbach JJV, Caffa M, Meuleman EJH, Rutten FFH. The cost utility of
ViagraTM in the Netherlands. Institute for Medical Technology
Assessment, Erasmus University Rotterdam, 1999
I have held a large number of
oral and poster presentations at international conferences of Society for
Medical Decision Making conference (2004), Nederlandse
Vereniging voor Technology
Assessment in de Gezondheidszorg (2003),
International Health Economics Association (1999 - 2005), International
Society for Pharmacoeconomics and Outcomes Research
(2002 – present), ISOQOL (2002),
ISTHAC (2000, 2002) Berlin, Ger: Integrating normative considerations into HTA
research: an empirical analysis shows that combining efficiency with severity
of the disease improves rational decision making Personal My hobbies are mainly outdoor activities. I enjoy playing soccer, fitness,
running, biking, and hiking. Last updated: October, 2008 |
